CLINICAL_TRIALS
trial_result
· 2009-08-06
Clinical Trial Update: The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia [Phase 3]
Summary
A Phase 3 study assessed varenicline for improving cognitive function in patients with schizophrenia; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inje University | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED